REFERENCES
- Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull WHO. 2004; 82(11)844–851, [PUBMED], [INFOTRIEVE], [CSA]
- Quigley H A, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997; 38(1)83–91, [PUBMED], [INFOTRIEVE], [CSA]
- Rahman M M, Rahman N, Foster P J, et al. The prevalence of glaucoma in Bangladesh: a population based survey in Dhaka division. Br J Ophthalmol. 2004; 88(12)1493–1497, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rahmani B, Tielsch J M, Katz J, et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology. 1996; 103(11)1721–1726, [PUBMED], [INFOTRIEVE], [CSA]
- Gordon M O, Beiser J A, Brandt J D, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120(6)714–720, discussion 829–830[PUBMED], [INFOTRIEVE], [CSA]
- Kass M A, Heuer D K, Higginbotham E J, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120(6)701–713, discussion 829–830[PUBMED], [INFOTRIEVE], [CSA]
- Weinreb R N, Khaw P T. Primary open-angle glaucoma. Lancet. 2004; 363(9422)1711–1720, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Strutton D R, Walt J G. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma. 2004; 13(3)221–226, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thomas R, Sekhar G C, Kumar R S. Glaucoma management in developing countries: medical, laser, and surgical options for glaucoma management in countries with limited resources. Curr Opin Ophthalmol. 2004; 15(2)127–131, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bateman D N, Clark R, Azuara-Blanco A, Bain M, Forrest J. The impact of new drugs on management of glaucoma in Scotland: observational study. Br Med J. 2001; 323(7326)1401–1402, [CSA]
- Baudouin C, Rouland J F, Le Pen C. Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France. Eur J Ophthalmol. 2003; 13(Suppl 4)S53–60, [PUBMED], [INFOTRIEVE], [CSA]
- Walland M J. Glaucoma treatment in Australia: changing patterns of therapy 1994–2003. Clin Exp Ophthalmol. 2004; 32(6)590–596, [CSA], [CROSSREF]
- Valk R V, Schouten J S, Webers C A, et al. The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries. J Glaucoma. 2005; 14(3)239–242, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]